Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Richeldi

Showing results (301-310 of 356) with videos related to

Pageof 36
Sort By:
American Journal of Respiratory and Critical Care Medicine|July 1, 2026
Opportunities for Human Lung Tissue-Based Studies in Fibrotic ILD ResearchJeffrey M Sturek, John S Kim, Anna Podolanczuk, et al.
The Lancet. Respiratory Medicine|November 21, 2017
Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White PaperDavid A Lynch, Nicola Sverzellati, William D Travis, et al.
Chest|March 26, 2009
Performance of tests for latent tuberculosis in different groups of immunocompromised patientsLuca Richeldi, Monica Losi, Roberto D'Amico, et al.
JCI Insight|June 9, 2016
Three-dimensional characterization of fibroblast foci in idiopathic pulmonary fibrosisMark G Jones, Aurélie Fabre, Philipp Schneider, et al.
JAMA|May 26, 2018
Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis: A Randomized Clinical TrialGanesh Raghu, Bernt van den Blink, Mark J Hamblin, et al.
Pulmonary Pharmacology & Therapeutics|July 2, 2017
Individualizing duration of antibiotic therapy in community-acquired pneumoniaStefano Aliberti, Julio Ramirez, Fabio Giuliani, et al.
American Journal of Respiratory and Critical Care Medicine|June 30, 2022
A Phase IIb Randomized Clinical Study of an Anti-α<sub>v</sub>β<sub>6</sub> Monoclonal Antibody in Idiopathic Pulmonary FibrosisGanesh Raghu, Majd Mouded, Daniel C Chambers, et al.
Cell Death & Disease|August 9, 2019
Autophagy inhibition-mediated epithelial-mesenchymal transition augments local myofibroblast differentiation in pulmonary fibrosisCharlotte Hill, Juanjuan Li, Dian Liu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 10, 2016
Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and ChildrenDavid M Lewinsohn, Michael K Leonard, Philip A LoBue, et al.
The New England Journal of Medicine|May 19, 2025
Nerandomilast in Patients with Progressive Pulmonary FibrosisToby M Maher, Shervin Assassi, Arata Azuma, et al.
Pageof 36

Showing results (301-310 of 356) with videos related to

Sort By:
Pageof 36
American Journal of Respiratory and Critical Care Medicine|July 1, 2026
Opportunities for Human Lung Tissue-Based Studies in Fibrotic ILD ResearchJeffrey M Sturek, John S Kim, Anna Podolanczuk, et al.
The Lancet. Respiratory Medicine|November 21, 2017
Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White PaperDavid A Lynch, Nicola Sverzellati, William D Travis, et al.
Chest|March 26, 2009
Performance of tests for latent tuberculosis in different groups of immunocompromised patientsLuca Richeldi, Monica Losi, Roberto D'Amico, et al.
JCI Insight|June 9, 2016
Three-dimensional characterization of fibroblast foci in idiopathic pulmonary fibrosisMark G Jones, Aurélie Fabre, Philipp Schneider, et al.
JAMA|May 26, 2018
Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis: A Randomized Clinical TrialGanesh Raghu, Bernt van den Blink, Mark J Hamblin, et al.
Pulmonary Pharmacology & Therapeutics|July 2, 2017
Individualizing duration of antibiotic therapy in community-acquired pneumoniaStefano Aliberti, Julio Ramirez, Fabio Giuliani, et al.
American Journal of Respiratory and Critical Care Medicine|June 30, 2022
A Phase IIb Randomized Clinical Study of an Anti-α<sub>v</sub>β<sub>6</sub> Monoclonal Antibody in Idiopathic Pulmonary FibrosisGanesh Raghu, Majd Mouded, Daniel C Chambers, et al.
Cell Death & Disease|August 9, 2019
Autophagy inhibition-mediated epithelial-mesenchymal transition augments local myofibroblast differentiation in pulmonary fibrosisCharlotte Hill, Juanjuan Li, Dian Liu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 10, 2016
Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and ChildrenDavid M Lewinsohn, Michael K Leonard, Philip A LoBue, et al.
The New England Journal of Medicine|May 19, 2025
Nerandomilast in Patients with Progressive Pulmonary FibrosisToby M Maher, Shervin Assassi, Arata Azuma, et al.
Pageof 36